Cultivation, manufacture, importation and exportation of medicinal cannabis is tightly controlled by the Office of Drug Control (ODC), the Therapeutic Goods Administration (TGA) and local state and territories.
Medicinal cannabis for patients
Medicinal cannabis and products are only available for specific patient groups under medical supervision. Medical practitioners will only be authorised to prescribe medicinal cannabis products for conditions where there is satisfactory scientific evidence supporting such use.
For medicinal cannabis information for consumers and patients the first step is to visit the Therapeutic Goods Administration.
Australian Advisory Council on the Medicinal Use of Cannabis
The AACMC, also known simply as the Council, provides advice to the Assistant Minister for Health and Aged Care on issues relating to the medicinal use of cannabis in accordance with the Therapeutic Goods Act 1989 and the implementation of the regulatory scheme under the Narcotic Drugs Act 1967.
- Media release: Medicinal cannabis licence holder fined for alleged inadequate securityThe ODC has issued an infringement notice to the New South Wales-based company A for alleged security failures at its cannabis cultivation site.
- Compliance and Enforcement Framework releasedRead about our approach to the regulated narcotic industry, and legal obligations for people with ODC licences.
- AACMC meeting 20, 9 December 2022The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #20.